EPO published patent application EP3819910A2 for Deep Bio Inc., a disease diagnosis system employing multiple color models combined with neural network analysis. The invention falls under IPC classifications G16H 50/20, G16H 30/40, and G16H 50/30 (Health Informatics). The patent is designated across 35 European states including Germany, France, UK, Italy, Spain, and other EPO member states.

This patent grant affects Deep Bio's competitors in the medical AI/diagnostics space. Healthcare technology companies, medical device manufacturers, and AI diagnostic developers should conduct freedom-to-operate analyses before developing similar color-model-based disease diagnosis systems. No immediate compliance actions are required, but entities relying on similar technology should review their IP exposure and consider licensing discussions with Deep Bio.